Rare diseases
Investigational molecules
Locations
Back to Germany329 clinical trials in Bad Oeynhausen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of anifrolumab effectiveness compared to placebo in adults aged 18-70 with systemic sclerosis
GermanyStudy on Deucravacitinib and Apremilast for Patients with Active Psoriatic Arthritis New to Biologic Treatments or Previously on TNFα Inhibitors
GermanyStudy on the Effectiveness and Safety of Ruxolitinib Cream for Patients with Prurigo Nodularis
GermanyStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
GermanyStudy on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
GermanyStudy Comparing Zimberelimab and Domvanalimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Untreated Metastatic Non-Small Cell Lung Cancer
GermanyStudy of BI 690517 and empagliflozin combination for protection of heart and kidneys in patients with chronic kidney disease
GermanyPhase 3 Study of INCB123667 versus investigator's choice of chemotherapy drug combination in patients with platinum‑resistant ovarian cancer and cyclin E1 overexpression
GermanyStudy comparing cagrilintide and semaglutide versus tirzepatide in people with type 2 diabetes taking metformin or SGLT2 inhibitor
GermanyA study testing DII235 compared to placebo in adults with high lipoprotein(a) levels to reduce heart disease risk
GermanyTesting Tarlatamab in Patients with Advanced Small-Cell Lung Cancer Who Have Poor Physical Condition
GermanyA study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials exploring treatments for heart failure and cardiovascular disease, including studies of novel compounds like baxdrostat and pelacarsen to reduce major cardiovascular events.
Advanced diagnostic approaches including PET imaging for coronary conditions.
Comprehensive research focusing on Type 2 Diabetes management and its complications, including studies on innovative treatments for diabetic peripheral neuropathy.
Novel therapeutic approaches for hypercholesterolemia and weight management.
Ground-breaking research in chronic kidney disease treatment, particularly focusing on complications associated with diabetes and hypertension.
Innovative therapies targeting kidney function preservation and disease progression.
Advanced research in hypertrophic cardiomyopathy and cardiac structural conditions, including maternal-fetal cardiac development studies.
Targeted therapies for specific cardiac conditions and preventive interventions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
